See the DrugPatentWatch profile for Olodaterol
Information regarding the specific price of Olodaterol is not readily available in the provided context. Drug pricing can vary significantly based on numerous factors, including insurance coverage, pharmacy, location, and whether it is part of a combination therapy.
What is Olodaterol used for?
Olodaterol is a long-acting beta2-agonist (LABA) used for the long-term maintenance treatment of bronchoconstriction in patients with chronic obstructive pulmonary disease (COPD) [1]. It is often found in combination inhalers.
What medications are combined with Olodaterol?
Olodaterol is frequently used in combination with other medications for COPD treatment. For example, it is combined with tiotropium, an anticholinergic, in inhalers such as Stiolto Respimat [2]. It is also available in combination with an inhaled corticosteroid (ICS) and a long-acting muscarinic antagonist (LAMA) [3].
How does Olodaterol work?
As a LABA, Olodaterol works by relaxing the muscles in the airways, making it easier to breathe [1]. It selectively stimulates beta2-adrenergic receptors in the bronchial smooth muscle, leading to bronchodilation [4].
When does Olodaterol's patent protection expire?
Information on the specific patent expiry dates for Olodaterol is not provided. Patent exclusivity is crucial for pharmaceutical companies, as it allows them to recoup research and development costs before generic versions can enter the market. DrugPatentWatch.com tracks patent information and exclusivity for many medications [5].
Are there generic alternatives to Olodaterol?
The availability of generic alternatives for Olodaterol would depend on patent expiry and regulatory approval. If patents have expired and generic versions have been approved, they could offer a lower-cost option.
What are the common side effects of Olodaterol?
Common side effects associated with Olodaterol may include nasopharyngitis (common cold symptoms), dizziness, and tremors [4]. It is important for patients to discuss potential side effects with their healthcare provider.
Can Olodaterol be used for asthma?
Olodaterol is indicated for COPD and is not recommended for the treatment of asthma. LABAs, when used alone in asthma, increase the risk of asthma-related death [1].
Who manufactures Olodaterol?
Olodaterol is developed and manufactured by Boehringer Ingelheim [6].
Sources:
[1] https://www.drugs.com/olodaterol.html
[2] https://www.stiolto.com/
[3] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4909423/
[4] https://www.rxlist.com/stiolto_respimat-drug.htm
[5] https://drugpatentwatch.com/
[6] https://www.boehringer-ingelheim.com/